Global Exosome Research Market 2022-2026

Dublin, May 23, 2022 /PRNewswire/—— “Global Global Market by Product and Service (Kits, Reagents, Instruments), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem Cells, Dendritic Cell Derivatives), End User and Region Exosome Research Market – Forecast to 2026” report added to’s supply.



The global exosome research market is valued at $144 million In 2021, it is expected to reach $661 million The compound annual growth rate is 35.6% over the forecast period to 2026, owing to increasing funding for life science research, high incidence of cancer worldwide, and increasing interest in exosome-based procedures.

The kits and reagents segment accounted for the largest share of the exosome research market by product and service

On the basis of products and services, the exosomes market is segmented into kits and reagents, instruments and services. The kits and reagents section is further divided into antibody, isolation, purification, quantification kits and reagents, and other kits and reagents.

Circulating exosomal microRNAs (miRNAs) have emerged as valuable candidate biomarkers, so these exosomes must be carefully characterized. This drives the use of these entities in exosome research to develop easy-to-use kits and reagents. Furthermore, isolation and purification are critical steps in exosome research protocols, contributing to their large-scale adoption in the market.

Asia-Pacific: Fastest Growing Regions in Exosome Research Market

this Asia-Pacific The exosome research market is growing at the fastest rate over the forecast period.Rising disposable income, infrastructure development, and penetration of cutting-edge diagnostic technologies in Asian countries, such as India and China Provides significant growth opportunities for manufacturers and distributors of exosomes.

North America: this North America The region accounts for the largest share of the exosome research market

North America Accounted for the largest share of the exosome research market. The United States is the major revenue generator for the North American exosome research market. High incidence of cancer coupled with increasing demand for early and effective disease diagnosis and treatment are key factors driving the growth of the U.S. market.

Competitive Landscape

Thermo Fisher Scientific (USA), QIAGEN NV (Netherlands), Bio-Techne (USA), System Biosciences, LLC. (US), NX PharmaGen (US), Miltenyi Biotechnology (Germany), AMS Biotechnology (Europe) Limited (UK), NanoSomiX (US), Lonza (Switzerland) and Norgen Biotek Corp. (Canada) are some of the leading players operating in the global exosome research market.

Advanced Insights

  • Increased investment in pharmaceutical industry to support market growth

  • The kits and reagents segment accounted for the largest share of the North American exosome research market in 2020

  • Lung cancer segment to dominate the market in 2026

Market dynamics




  • untapped emerging market

  • Growing interest in exosome-based therapies

  • High demand for personalized medicine


Impact of COVID-19 Outbreak on the Exosome Research Market

Ecosystem and value chain analysis

Regulatory Analysis

Company Featured

  • Aethlon Medical Corporation

  • AMSBio (ams Biotechnology)

  • Anjarium Biosciences AG

  • Biotechnology

  • BioVision

  • Cell Guidance Systems LLC

  • Siloa

  • Clara Biotech

  • Creative Medical Technology Holdings

  • eternal life

  • External use

  • Elias Biologics

  • Inoviq (Bard1 Life Sciences Ltd.)

  • Lonza

  • Miltenyi Biotechnology

  • Nanosomix, Inc.

  • Nanoview Bioscience

  • norwegian biotech

  • Novus Biologics

  • NX Pharmagen

  • Pall Corporation

  • Chigan

  • Lyon LLC

  • Systems Biosciences LLC

  • Thermo Fisher Scientific

For more information on this report, please visit

Media Contact:

Research and Marketing
Laura WoodSenior Manager
[email protected]

EST Office Hours Call +1-917-300-0470
US/Canada Toll Free +1-800-526-8630
GMT Office Hours Call +353-1-416-8900

US Fax: 646-607-1907
Fax (outside the US): +353-1-481-1716



View original content:—opportunities-in-untapped-emerging-markets-growth-interest-in-exosome-based-therapeutics- – High demand for personalized medicine – 301552728.html


Leave a Reply

Your email address will not be published. Required fields are marked *